. Structural biology for drug design (Canada);
Employees: 11-50
Total raised: $40M
Investors 2
| Date | Name | Website |
| 02.02.2022 | Air Street... | airstreet.... |
| 03.09.2021 | Lux Capita... | luxcapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.01.2022 | Series A | $40M | - |
Mentions in press and media 12
| Date | Title | Description |
| 31.03.2023 | Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution | Gandeeva Therapeutics, a precision medicine company focused on designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the initiation of a research collaboration wi... |
| 08.02.2022 | Funding news: Materials maker lands $14M, cybersecurity startup raises $4.5M, and more | (Modumetal Photo) Here’s a roundup of recent funding news from Pacific Northwest startups: Modumetal, a Seattle-area industrial startup that makes coating technologies, raised $14 million in a round led by Atlas Innovate and Rotor Capital. ... |
| 01.02.2022 | Gandeeva brings in $40M Series A | Gandeeva Therapeutics has raised $40 million in a round co-led by Lux Capital and Leaps by Bayer, with support from Obvious Ventures, Amgen Ventures, Amplitude Ventures and Air Street Capital. The precision biotech company is developing the... |
| 31.01.2022 | The metaverse could be ripe for crime, child abuse, and misinformation without regulation | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. If you’ve struggled to envision your virtual self in the metaverse, you’re not alone. Paid Conten... |
| 31.01.2022 | Canadian biotech startup Gandeeva Therapeutics raises USD 40 million in Series A | - |
| 31.01.2022 | Gandeeva Raises $40M in Series A Funding | Gandeeva Therapeutics, a Vancouver, BC, Canada-based precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel therapeutics at an accelerated pace, raised US$40m in... |
| 31.01.2022 | Gandeeva Therapeutics raises $40m zoom in on biomolecules – and create new drugs in the process | The field scientists once jokingly called “blobography” has come a long way. Cryogenic electron microscopy was formerly known for delivering amorphous images of biomolecules. Now it has become one of the highest fidelity methods available f... |
| 31.01.2022 | Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions | Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel therapeutics at an accelerated pace, today announced it has raised US$40 million ... |
| 31.01.2022 | The metaverse could be ripe for crime, child abuse, and misinformation without regulation | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. If you’ve struggled to envision your virtual self in the metaverse, you’re not alone. Paid Conten... |
| - | Gandeeva CEO shares how integrating AI with cryo-electron microscopy can support drug discovery | Gandeeva Therapeutics, founded in 2021, is developing precision imaging solutions with the integration of cryo-electron microscopy (cryo-EM) and artificial intelligence. In an interview, CEO and Founder Sriram Subramaniam said its technolog... |
Show more